subsidiary (AIL) of 17.31 million Baht and allowance for doubtful accounts of 2.78 million Baht. The fluctuation of CPO price mentioned above had reflected the Company's business operation in the production
production capacity to be in line with a slowdown in inventory turnover from sales revenue setbacks. This reduction in production capacity is expected to affect fixed cost allocation and marginally increase
, upgrading technology in order to increase output of HDI products and the unexpected appreciation of the THB against foreign currencies, which had the effect of a decline in sales revenue, a low production
. Other income decreased by 1.42 million baht or 7.19 % from the year 2016. Main reason why the revenue from the sale of scrap was reduced because the waste in the production process was reduced by
increased from the year of 2016 by THB 62.32 million or 11.68 %. Sales volume of Crude Glycerin has been increased due to an increase in Biodiesel’s production and sale and the Crude Glycerin price. 1.3
increased from the year of 2016 by THB 62.32 million or 11.68 %. Sales volume of Crude Glycerin has been increased due to an increase in Biodiesel’s production and sale and the Crude Glycerin price. 1.3
. However, the higher cost of goods sold was lower as it was partially offset by higher production volumes supported by an increase in capacity utilization of Phase 3 at the new plant. The average profit
revenue is decreased by 1.1 percent compared to the same quarter of the previous year (increased by 1.3 percent from Q1/2019) , thanks to the resources for production to accommodate sales in China, despite
Company and subsidiaries established the cost efficiency projects to optimize the production cost, waste management and tighter control of purchasing raw material to in- line with reduction in sales and
per year. The plant is expected to be the largest single line vertically integrated PTA-PET production facility in the world and the largest PTA plant in the Americas. Pursuant to the terms of the newly